Deprescribing Programmes · Tow Law

Deprescribing Programmes in Tow Law.

Safe, evidenced deprescribing — focused on PPIs, hypnotics, opioids, anticholinergics and end-of-life regimens, with patient consent recorded. Delivered to Tow Law PCNs and GP practices from the BCS Halifax (West Yorkshire) hub — with paired cover from our Chiswick (West London) hub. BCS is the only UK provider operating this dual-hub clinical pharmacy model.

Dual-hub delivery

The only UK provider with a Yorkshire + London hub.

Every deprescribing programmes placement in Tow Law is mobilised from one of our two clinical hubs — Halifax (West Yorkshire) as the lead and Chiswick (West London) as paired cover. The dual-hub model is unique to BCS: no other clinical pharmacy provider in the UK runs Northern and Southern hubs with shared SOPs, shared supervision and same-week cross-cover. That is what guarantees continuity of deprescribing programmes for a Tow Law PCN through sickness, leave and turnover.

  • Lead delivery from the BCS Halifax (West Yorkshire) hub
  • Paired cover from BCS Chiswick (West London) — same SOPs, same supervision
  • Same-week sickness, leave and maternity cover guaranteed
  • ARRS-compliant, GPhC-registered, IP-qualified workforce
  • One SLA, one report, one escalation point

Tow Law · local context

Tow Law PCNs sit within NHS North East and North Cumbria ICB.

Tow Law PCNs combine larger urban practices with smaller former-pit-village branches — BCS combines on-site days with HSCN-secured remote prescribing for branch sites.

What you get

What deprescribing programmes in Tow Law actually looks like.

  • PPI step-down and stop pathways
  • Hypnotic and z-drug deprescribing
  • Opioid review and taper
  • Anticholinergic burden reduction
  • End-of-life rationalisation

Tow Law · what good looks like

Typical first-year markers.

4–6 wks
Mobilisation in Tow Law
2 hubs
Halifax + Chiswick — unique to BCS
100%
Supervision evidenced for audit
Monthly
QA-checked outcomes report

Why Tow Law PCNs choose BCS for deprescribing programmes.

Solo recruitment for deprescribing programmes in Tow Law leaves a network exposed to sickness, maternity and retention risk, and rarely meets the supervision standard ICBs now ask for. BCS removes all of that — pharmacists are part of a clinical team, supervision is built in, and continuity is guaranteed by the Halifax (West Yorkshire)/Chiswick (West London) dual-hub.

Whether you are a single Tow Law PCN starting your first deprescribing programmes programme, or a federation coordinating deprescribing programmes across multiple North East networks, the BCS managed model scales without changing your contract.

Frequently asked questions — Deprescribing Programmes in Tow Law.

How do you handle patient pushback?+

Every deprescribing decision is shared with the patient and documented; we never deprescribe without consent.

Does BCS already deliver deprescribing programmes in Tow Law?+

BCS supports PCNs and GP practices across North East from our Halifax (West Yorkshire) hub with paired cover from Chiswick (West London), and is actively delivering or available to mobilise deprescribing programmes in Tow Law. Get in touch and we'll confirm current capacity.

What makes the dual-hub model different?+

BCS is the only UK clinical pharmacy provider running both a Northern (Halifax) and Southern (Chiswick) hub. That means same-week cross-cover, one SOP set across the country, and no service gap when staff are off — something single-hub or single-region providers cannot match.

How quickly can BCS mobilise deprescribing programmes in Tow Law?+

In most cases BCS mobilises deprescribing programmes for a Tow Law PCN within 4 to 6 weeks of contract sign-off, with remote prescribing back-up available from the hub sooner if needed.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call